AKT1 and prostate cancer: The COSMIC database analysis of mutations in the three Akt isoforms found in cancer patients confirmed earlier reports about the occurrence of activating E17K mutations in the pleckstrin homology domain in various types of tumours – including frequently occurring tumours that are treated with radiotherapy such as skin, breast and prostate cancer (Fig. 1A).